Gyre Therapeutics Stock Analysis

Gyre Stock Analysis Notes

About 75.0% of the company shares are held by company insiders. The company recorded a loss per share of 1.04. Gyre Therapeutics last dividend was issued on the 12th of January 2023. The entity had 1:15 split on the 31st of October 2023. To learn more about Gyre Therapeutics call Han Ying at 619-949-3681 or check out https://www.gyretx.com.

Gyre Therapeutics Investment Alerts

Gyre Therapeutics Upcoming and Recent Events

Gyre Largest EPS Surprises

View All Earnings Estimates

Gyre Therapeutics Environmental, Social, and Governance (ESG) Scores

Gyre Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.11 B.

Gyre Profitablity

The company has Profit Margin (PM) of (0.77) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.13 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.13.

Management Efficiency

Gyre Therapeutics has return on total asset (ROA) of 0.1018 % which means that it generated a profit of $0.1018 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.8274) %, meaning that it created substantial loss on money invested by shareholders. Gyre Therapeutics' management efficiency ratios could be used to measure how well Gyre Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Equity is expected to grow to 6.17, whereas Return On Tangible Assets are forecasted to decline to (0.85). At present, Gyre Therapeutics' Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Total Current Assets is expected to grow to about 88 M, whereas Intangible Assets are forecasted to decline to about 194.8 K.

Technical Drivers

As of the 22nd of November, Gyre Therapeutics retains the Downside Deviation of 4.49, market risk adjusted performance of 0.109, and Risk Adjusted Performance of 0.0493. Gyre Therapeutics technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Please check out Gyre Therapeutics variance, value at risk, as well as the relationship between the Value At Risk and skewness to decide if Gyre Therapeutics is priced fairly, providing market reflects its last-minute price of 11.75 per share. Given that Gyre Therapeutics has jensen alpha of 0.0325, we strongly advise you to confirm Gyre Therapeutics's regular market performance to make sure the company can sustain itself at a future point.

Gyre Therapeutics Price Movement Analysis

Gyre Therapeutics Insider Trading Activities

Gyre Therapeutics Predictive Daily Indicators

Gyre Therapeutics Corporate Filings

Gyre Therapeutics Forecast Models

Gyre Therapeutics' time-series forecasting models are one of many Gyre Therapeutics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Gyre Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Gyre Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Gyre shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Gyre Therapeutics. By using and applying Gyre Stock analysis, traders can create a robust methodology for identifying Gyre entry and exit points for their positions.

When running Gyre Therapeutics' price analysis, check to measure Gyre Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gyre Therapeutics is operating at the current time. Most of Gyre Therapeutics' value examination focuses on studying past and present price action to predict the probability of Gyre Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gyre Therapeutics' price. Additionally, you may evaluate how the addition of Gyre Therapeutics to your portfolios can decrease your overall portfolio volatility.